Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Article in English | MEDLINE | ID: mdl-37754646

ABSTRACT

INTRODUCTION: Research addressing the costs of Medication errors (MEs) is still scarce despite issues related to patient safety having significant economic and health impacts, making it imperative to analyze the costs and adverse events related to MEs for a better patient, professional, and institutional safety. AIM: To identify the number of medication errors and verify whether this number was associated with increased hospitalization costs for patients in an Intensive Care Unit (ICU). METHOD: This retrospective cross-sectional cohort study evaluated secondary data from patients' electronic medical records to compile variables, create a model, and survey hospitalization costs. The statistical analysis included calculating medication error rates, descriptive analysis, and simple and multivariate regression. RESULTS: The omission error rate showed the highest number of errors per drug dose (59.8%) and total errors observed in the sample (55.31%), followed by the time error rate (26.97%; 24.95%). The omission error had the highest average when analyzing the entire hospitalization (170.40) and day of hospitalization (13.79). Hospitalization costs were significantly and positively correlated with scheduling errors, with an increase of BRL 121.92 (about USD $25.00) (95% CI 43.09; 200.74), and to prescription errors, with an increase of BRL 63.51 (about USD $3.00) (95% CI 29.93; 97.09). CONCLUSION: We observed an association between two types of medication errors and increased hospitalization costs in an adult ICU (scheduling and prescription errors).

2.
Interface (Botucatu, Online) ; 26: e210619, 2022. tab, ilus
Article in Portuguese | LILACS | ID: biblio-1385939

ABSTRACT

As percepções e o uso de metilfenidato entre universitários foram investigados em estudo descritivo realizado em duas etapas. A primeira, quantitativa, foi realizada por meio do preenchimento de um questionário semiestruturado on-line. Para a segunda etapa, qualitativa, foi realizado um grupo focal. Dos 337 participantes da primeira etapa, 14,5% relataram usar o metilfenidato. Entre os usuários, a prevalência de uso sem prescrição foi maior para o sexo masculino (65,3%), após ingresso na faculdade (57,1%), e 61,2% relataram eventos adversos. O principal motivo de uso foi o doping intelectual (65,3%). Já na etapa qualitativa, além de reforçar os achados anteriores, foram identificados tópicos temáticos como a pressão externa exercida por familiares, sociedade e a rotina universitária. Esses achados apontam para a necessidade de medidas de apoio e orientação aos universitários e de reformulação do processo ensino-aprendizagem.(AU)


This descriptive study investigated the use and perceptions of methylphenidate among university students. The study was conducted in two stages. In the first stage (quantitative), the students completed an online semi-structured questionnaire. The second stage (qualitative) consisted of focus group discussions. Of the 337 participants in the first stage, 14.5% reported using methylphenidate. The prevalence of methylphenidate use without a prescription was greater among men (65.3%) and after starting university (57.1%); 61.2% of the students reported adverse events. The main reason for using the drug was intellectual doping (65.3%). In the qualitative stage, which reinforced the findings of the quantitative stage, we identified themes such as external pressure from family, society and university routine. The findings underline the need to provide student support and advice and reformulate the teaching and learning process.(AU)


Se investigaron las percepciones y el uso del metilfenidato entre universitarios, en un estudio descriptivo realizado en dos etapas. La primera, cuantitativa, se realizó por medio del llenado de un cuestionario semiestructurado online. Para la segunda etapa, cualitativa, se realizó un grupo focal. De los 337 participantes de la primera etapa, el 14,5% relató que usaba metilfenidato. Entre los usuarios, la prevalencia de uso sin prescripción fue mayor para el sexo masculino (65,3%), después del ingreso en la facultad (57,1%) y el 61,2% relataron eventos adversos. El principal motivo de uso fue el dopping intelectual (65,3%). En la etapa cualitativa, además de reforzar los hallazgos anteriores, se identificaron tópicos temáticos tales como la presión externa ejercida por los familiares, la sociedad y la rutina universitaria. Esos hallazgos señalan la necesidad de medidas de apoyo y orientación a los universitarios y de reformulación del proceso enseñanza-aprendizaje.(AU)


Subject(s)
Humans , Male , Female , Adult , Students, Health Occupations , Off-Label Use/statistics & numerical data , Methylphenidate , Brazil
3.
Front Pharmacol ; 12: 740383, 2021.
Article in English | MEDLINE | ID: mdl-34671259

ABSTRACT

The effectiveness of antiretroviral treatment has transformed HIV infection into a chronic transmissible condition, requiring health systems to adapt in order to care for people living with HIV. The Chronic Care Model (CCM) is the gold standard for this type of care in many countries. Among its tools, the Patient Assessment of Chronic Illness Care (PACIC) questionnaire gives the patient's perspective of the care provided. The aim of the present study was to adapt and apply, for the first time, the questionnaire to people living with HIV to determine their perception of the quality of care provided at a reference hospital in the Federal District of Brazil. This is a case study conducted in 2019 at a teaching hospital, with a convenience sample of 30 individuals treated for at least 1 year at the facility. The median PACIC score (3.5 with a range of 1.0-5.0) seems to suggest that the users perceive the outpatient care provided by the hospital as being basic. The "delivery system design/decision support" component was deemed the best (5.0, with a range of 1.0-5.0) and "follow-up/coordination" the worst (1.0, with a range of 1.0-5.0). The results suggest the need to improve the organization of care and make adequate use of community resources, in line with the CCM. The questionnaire makes it possible to determine the strengths and weaknesses of the care provided to people living with HIV and can be used as a planning and monitoring tool to improve management of the condition, with the contribution of the patient, in particular, thereby strengthening self-care.

4.
Front Pharmacol ; 10: 165, 2019.
Article in English | MEDLINE | ID: mdl-30873036

ABSTRACT

The effectiveness of antiretroviral therapy has rendered HIV infection a manageable chronic condition. Currently, the health systems face the challenge of adopting organizational healthcare models capable of ensuring the delivery of comprehensive care. The Chronic Care Model has been reported for its effectiveness, particularly in terms of delivery system design. In this study, the Assessment of Chronic Illness Care (ACIC) questionnaire, a soft technology widely used for other chronic conditions, was employed on a teaching hospital to evaluate healthcare provided to people living with HIV/AIDS. The ACIC technology is a self-explanatory instrument which diagnoses, among the six components of the Chronic Care Model Framework, areas for quality improvements, indicating at the same time, intervention strategies and achievements. These components are healthcare network organization, delivery system design, self-management support, decision support, clinical information systems, and community. From May to October 2014, the tool was applied to the multidisciplinary teamwork at the points of care identified, as well as to the hospital management board. Respondents broadly rated care as basic. A pronounced contrast was observed from evaluation by management board and health professional staff in some components like organization of healthcare and clinical information system. The self-management support and delivery system design were the components best evaluated by the multidisciplinary team. Combined with the array of services offered, the entry points available at the hospital can ensure healthcare comprehensiveness. However, some gaps were detected, precluding the delivery of an effective care. The ACIC was considered an adequate technology to provide knowledge of the gaps, to promote productive discussions and reflections within teams and to indicate actions to achieve improvements on healthcare for people living with HIV/AIDS.

5.
Rev Bras Epidemiol ; 20(3): 445-459, 2017.
Article in Portuguese, English | MEDLINE | ID: mdl-29160437

ABSTRACT

OBJECTIVE: To describe people with diabetes in Brazil and to compare their sociodemographic characteristics, access and self-reported adherence to diabetes prescribed drugs. METHODS: Data analysis from the National Survey on Access, Use and Promotion of the Rational Use of Medicines, a household survey, with sampling by clusters, according to sex and age domains and national and macro-regional representativeness. Adults (≥ 20 years old) who reported having diabetes constituted the sample. The weighted frequencies of the variables in the sample were analyzed and the Pearson χ2 test was applied to evaluate the statistical significance of the differences between the strata for the data of access, form of financing and adherence to the drugs, considering the level of significance of 5%. RESULTS: We found a higher proportion of women, people over 60 years and economy class C. Most participants reported having two or more comorbidities, in addition to diabetes, and taking five or more drugs. Regarding access, 97.8% say they have access to prescription drugs for diabetes and 70.7% say they get them totally free of charge. There was low adherence to anti-diabetic treatment, with significant macro-regional differences (p = 0,001), and greater vulnerability in the South and Northeast regions. CONCLUSION: Better access to diabetes medicines in the country has been demonstrated. However, to improve the efficiency of health public spending, it is necessary to achieve higher rates of adherence to treatment.


OBJETIVO: Descrever as pessoas com diabetes no Brasil e comparar suas características sociodemográficas, o acesso e a adesão autorreferida aos medicamentos prescritos. MÉTODOS: Análise de dados oriundos da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos, um inquérito domiciliar, com plano amostral por conglomerados, segundo domínios de sexo e idade e representatividade nacional e macrorregional. Os adultos (≥ 20 anos) que referiram ter diabetes constituíram a amostra. Analisaram-se as frequências ponderadas das variáveis na amostra e aplicou-se o teste do χ2 de Pearson para avaliar a significância estatística das diferenças entre os estratos para os dados de acesso, forma de financiamento e adesão aos medicamentos, considerando o nível de significância de 5%. RESULTADOS: Encontrou-se uma maior proporção de mulheres, de maiores de 60 anos e da classe econômica C. A maioria referiu ter duas ou mais comorbidades além do diabetes e tomar cinco ou mais medicamentos. Quanto ao acesso, 97,8% dizem ter acesso aos medicamentos prescritos para diabetes e 70,7%, que os obtêm de forma totalmente gratuita. Verificou-se baixa adesão ao tratamento farmacológico, com diferenças macrorregionais significativas (p = 0,001) e maior vulnerabilidade nas regiões sul e nordeste. CONCLUSÃO: Demonstrou-se melhor acesso aos medicamentos para diabetes no país. Entretanto, para melhorar a eficiência dos gastos públicos, ficou demonstrada a necessidade de melhorar a adesão ao tratamento medicamentoso.


Subject(s)
Diabetes Mellitus/drug therapy , Health Services Accessibility/statistics & numerical data , Medication Adherence/statistics & numerical data , Adult , Brazil , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Socioeconomic Factors , Young Adult
6.
Rev Saude Publica ; 51(suppl 2): 9s, 2017 Nov 13.
Article in English, Portuguese | MEDLINE | ID: mdl-29160450

ABSTRACT

OBJECTIVE: To characterize the process of selection of medicines for primary health care in the Brazilian regions. METHODS: This article is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos - Serviços, 2015 (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines - Services, 2015), a cross-sectional study that consisted of an information gathering in a sample of cities in the five regions of Brazil. The data used were collected by interviews with those responsible for pharmaceutical services (PS) (n = 506), professionals responsible for the dispensing of medicines (n = 1,139), and physicians (n = 1,558). To evaluate the difference between ratios, we adopted the Chi-square test for complex samples. The differences between the averages were analyzed in generalized linear models with F-test with Bonferroni correction for multiple comparisons. The analyses considered significant had p≤0.05. RESULTS: The professionals responsible for pharmaceutical services reported non-existence of a formally constituted Pharmacy and Therapeutics Committee (PTC) (12.5%). They claimed to have an updated (80.4%) list of Essential Medicines (85.3%) and being active participants of this process (88.2%). However, in the perception of respondents, the list only partially (70.1%) meets the health demands. Of the interviewed professionals responsible for the dispensing of medicines, only 16.6% were pharmacists; even so, 47.8% reported to know the procedures to change the list. From the perspective of most of these professionals (70.9%), the list meets the health demands of the city. Among physicians, only 27.2% reported to know the procedures to change the list, but 76.5% would have some claim to change it. Most of them reported to base their claims in clinical experiences (80.0%). For 13.0% of them, the list meets the health demands. CONCLUSIONS: As this is the first national survey of characterization of the process of selection of medicines within primary health care, it brings unpublished data for the assessment of policies related to medicines in Brazil.


Subject(s)
Drugs, Essential/classification , Health Services Accessibility/statistics & numerical data , Pharmaceutical Services/statistics & numerical data , Adult , Brazil , Cross-Sectional Studies , Drugs, Essential/supply & distribution , Female , Health Surveys , Humans , Male , National Health Programs , Primary Health Care , Sex Distribution , Socioeconomic Factors
7.
Rev. bras. epidemiol ; 20(3): 445-459, Jul.-Set. 2017. tab, graf
Article in Portuguese | LILACS | ID: biblio-898599

ABSTRACT

RESUMO: Objetivo: Descrever as pessoas com diabetes no Brasil e comparar suas características sociodemográficas, o acesso e a adesão autorreferida aos medicamentos prescritos. Métodos: Análise de dados oriundos da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos, um inquérito domiciliar, com plano amostral por conglomerados, segundo domínios de sexo e idade e representatividade nacional e macrorregional. Os adultos (≥ 20 anos) que referiram ter diabetes constituíram a amostra. Analisaram-se as frequências ponderadas das variáveis na amostra e aplicou-se o teste do χ2 de Pearson para avaliar a significância estatística das diferenças entre os estratos para os dados de acesso, forma de financiamento e adesão aos medicamentos, considerando o nível de significância de 5%. Resultados: Encontrou-se uma maior proporção de mulheres, de maiores de 60 anos e da classe econômica C. A maioria referiu ter duas ou mais comorbidades além do diabetes e tomar cinco ou mais medicamentos. Quanto ao acesso, 97,8% dizem ter acesso aos medicamentos prescritos para diabetes e 70,7%, que os obtêm de forma totalmente gratuita. Verificou-se baixa adesão ao tratamento farmacológico, com diferenças macrorregionais significativas (p = 0,001) e maior vulnerabilidade nas regiões sul e nordeste. Conclusão: Demonstrou-se melhor acesso aos medicamentos para diabetes no país. Entretanto, para melhorar a eficiência dos gastos públicos, ficou demonstrada a necessidade de melhorar a adesão ao tratamento medicamentoso.


ABSTRACT: Objective: To describe people with diabetes in Brazil and to compare their sociodemographic characteristics, access and self-reported adherence to diabetes prescribed drugs. Methods: Data analysis from the National Survey on Access, Use and Promotion of the Rational Use of Medicines, a household survey, with sampling by clusters, according to sex and age domains and national and macro-regional representativeness. Adults (≥ 20 years old) who reported having diabetes constituted the sample. The weighted frequencies of the variables in the sample were analyzed and the Pearson χ2 test was applied to evaluate the statistical significance of the differences between the strata for the data of access, form of financing and adherence to the drugs, considering the level of significance of 5%. Results: We found a higher proportion of women, people over 60 years and economy class C. Most participants reported having two or more comorbidities, in addition to diabetes, and taking five or more drugs. Regarding access, 97.8% say they have access to prescription drugs for diabetes and 70.7% say they get them totally free of charge. There was low adherence to anti-diabetic treatment, with significant macro-regional differences (p = 0,001), and greater vulnerability in the South and Northeast regions. Conclusion: Better access to diabetes medicines in the country has been demonstrated. However, to improve the efficiency of health public spending, it is necessary to achieve higher rates of adherence to treatment.


Subject(s)
Humans , Male , Female , Adult , Young Adult , Diabetes Mellitus/drug therapy , Medication Adherence/statistics & numerical data , Socioeconomic Factors , Brazil , Cross-Sectional Studies , Health Services Accessibility/statistics & numerical data , Middle Aged
8.
Rev. saúde pública (Online) ; 51(supl.2): 9s, 2017. tab
Article in English | LILACS | ID: biblio-903405

ABSTRACT

ABSTRACT OBJECTIVE To characterize the process of selection of medicines for primary health care in the Brazilian regions. METHODS This article is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos - Serviços, 2015 (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines - Services, 2015), a cross-sectional study that consisted of an information gathering in a sample of cities in the five regions of Brazil. The data used were collected by interviews with those responsible for pharmaceutical services (PS) (n = 506), professionals responsible for the dispensing of medicines (n = 1,139), and physicians (n = 1,558). To evaluate the difference between ratios, we adopted the Chi-square test for complex samples. The differences between the averages were analyzed in generalized linear models with F-test with Bonferroni correction for multiple comparisons. The analyses considered significant had p≤0.05. RESULTS The professionals responsible for pharmaceutical services reported non-existence of a formally constituted Pharmacy and Therapeutics Committee (PTC) (12.5%). They claimed to have an updated (80.4%) list of Essential Medicines (85.3%) and being active participants of this process (88.2%). However, in the perception of respondents, the list only partially (70.1%) meets the health demands. Of the interviewed professionals responsible for the dispensing of medicines, only 16.6% were pharmacists; even so, 47.8% reported to know the procedures to change the list. From the perspective of most of these professionals (70.9%), the list meets the health demands of the city. Among physicians, only 27.2% reported to know the procedures to change the list, but 76.5% would have some claim to change it. Most of them reported to base their claims in clinical experiences (80.0%). For 13.0% of them, the list meets the health demands. CONCLUSIONS As this is the first national survey of characterization of the process of selection of medicines within primary health care, it brings unpublished data for the assessment of policies related to medicines in Brazil.


RESUMO OBJETIVO Caracterizar o processo de seleção de medicamentos na atenção primária à saúde, nas regiões brasileiras. MÉTODOS Artigo integrante da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos - Serviços 2015, um estudo transversal que envolveu o levantamento de informações numa amostra de municípios das cinco regiões do Brasil. Os dados utilizados foram coletados por meio de entrevistas com os responsáveis pela assistência farmacêutica (n = 506), profissionais que realizam a dispensação de medicamentos (n = 1.139) e médicos (n = 1.558). Para avaliar a diferença entre as proporções foi adotado o teste do qui-quadrado para amostras complexas. As diferenças entre as médias foram analisadas em modelos lineares generalizados, com teste F com correção de Bonferroni para comparações múltiplas. Foram significativas as análises com valores de p ≤ 0,05. RESULTADOS Os responsáveis da assistência farmacêutica relataram não haver Comissão de Farmácia e Terapêutica formalmente constituída (12,5%). Eles afirmaram possuir uma Lista de Medicamentos Essenciais (85,3%) atualizada (80,4%), e serem participantes deste processo (88,2%). Contudo, na percepção dos entrevistados a Lista atende apenas parcialmente (70,1%) as demandas de saúde. Dos profissionais que realizam a dispensação de medicamentos entrevistados, apenas 16,6% eram farmacêuticos, mesmo assim, 47,8% referiram conhecer os procedimentos para mudança da lista. Na perspectiva da maior parte desses profissionais (70,9%), a lista atende as demandas de saúde do município. Dentre os médicos apenas 27,2% declararam ter conhecimento dos procedimentos para mudança da lista, mas 76,5% teriam alguma reivindicação de alteração. A maior parte reporta que baseia suas reivindicações em experiências clínicas (80,0%); para 13,0% deles, a lista atende às demandas de saúde. CONCLUSÕES Por tratar-se da primeira pesquisa nacional de caracterização do processo de seleção de medicamentos no âmbito da atenção primária à saúde, traz dados inéditos para a avaliação das políticas relacionadas com medicamentos no Brasil.


Subject(s)
Humans , Male , Female , Adult , Pharmaceutical Services/statistics & numerical data , Drugs, Essential/classification , Health Services Accessibility/statistics & numerical data , Primary Health Care , Socioeconomic Factors , Brazil , Cross-Sectional Studies , Health Surveys , Sex Distribution , Drugs, Essential/supply & distribution , National Health Programs
9.
Rev Soc Bras Med Trop ; 49(6): 763-767, 2016.
Article in English | MEDLINE | ID: mdl-28001225

ABSTRACT

INTRODUCTION:: Despite the therapeutic benefits of drugs, adverse drug reactions (ADRs) occur. Method: We assessed a series of suspected ADRs identified from notifications and intensive monitoring of inpatients from March 2013 to March 2014. RESULTS:: Skin reactions predominated (31%). Systemic anti-infective agents were implicated in 16 (72%) reactions. Fifteen (68%) ADRs were classified as possible. The implicated drug was not correctly identified by the healthcare team in 12 cases. CONCLUSIONS:: Some reactions were not correctly attributed to the causative drug(s), suggesting that the use of a validated evaluation method can promote successful identification of causal links between ADRs and drugs.


Subject(s)
Communicable Diseases/drug therapy , Drug-Related Side Effects and Adverse Reactions/epidemiology , Adult , Brazil/epidemiology , Female , Hospitals, Teaching/statistics & numerical data , Humans , Male , Middle Aged
10.
Rev. Soc. Bras. Med. Trop ; 49(6): 763-767, Dec. 2016. tab
Article in English | LILACS | ID: biblio-1041390

ABSTRACT

Abstract INTRODUCTION: Despite the therapeutic benefits of drugs, adverse drug reactions (ADRs) occur. Method: We assessed a series of suspected ADRs identified from notifications and intensive monitoring of inpatients from March 2013 to March 2014. RESULTS: Skin reactions predominated (31%). Systemic anti-infective agents were implicated in 16 (72%) reactions. Fifteen (68%) ADRs were classified as possible. The implicated drug was not correctly identified by the healthcare team in 12 cases. CONCLUSIONS: Some reactions were not correctly attributed to the causative drug(s), suggesting that the use of a validated evaluation method can promote successful identification of causal links between ADRs and drugs.


Subject(s)
Humans , Male , Female , Adult , Communicable Diseases/drug therapy , Drug-Related Side Effects and Adverse Reactions/epidemiology , Brazil/epidemiology , Hospitals, Teaching/statistics & numerical data , Middle Aged
11.
Epidemiol. serv. saúde ; 21(1): 55-68, jan.-mar. 2012. graf, tab
Article in Portuguese | LILACS | ID: lil-619590

ABSTRACT

Objetivo: apresentar a metodologia e resultados da implantação da vigilância de fatores de risco e proteção para doenças e agravos não transmissíveis (DANT) em município de pequeno porte, Anchieta, no estado do Espírito Santo, Brasil, em 2010. Métodos: estudo transversal de base populacional com realização de exames bioquímicos, aferição da pressão arterial, avaliação antropométrica e eletrocardiograma da população-alvo. Resultados: aproximadamente 25,0 por cento dos entrevistados relataram consumo regular de refrigerante, 45,2 por cento, carne com gordura, e 22,5 por cento, abuso de bebida alcoólica; 14,1 por cento referiram ser inativos, 16,2 por cento, fumantes, 52,1 por cento apresentaram excesso de peso auto-referido, e 16,9 por cento, obesidade; sobre fatores de proteção, 5,0 por cento da população referiu consumir frutas e hortaliças conforme recomendado, e 3,6 por cento, atividade física no lazer; a prevalência de uso de cinto de segurança no banco da frente foi de 74,0 por cento, e 83,5 por cento dos motociclistas referiram utilizar capacete; entre os indivíduos que realizaram exames, 49,2 por cento apresentaram hipercolesterolemia, 46,0 por cento, lesão renal, 19,0 por cento, alteração em eletrocardiograma e 5,8 por cento, diabetes. Conclusão: a metodologia utilizada permitiu conhecer a prevalência dos fatores de risco e proteção para DANT em município de pequeno porte; ações de promoção da saúde, vigilância, prevenção e atenção estão sendo elaboradas com base nos resultados encontrados.


Objective: to present the methodology and results of the implementation of surveillance for risk and protective factors for non-communicable diseases (NCD) and injuries in a small city, Anchieta, in the State of Espírito Santo, Brazil, in 2010. Methods: a population-based cross sectional study with blood sample collection, blood pressure, anthropometric measurements and electrocardiogram of the target-population. Results: approximately 25.0 per cent adults interviewed reported drinking soft drinks regularly, 45.2 per cent, eat meat with visible fat, and 22.5 per cent, harmful use of alcohol; 14.1 per cent reported physical inactivity, 16.2 per cent, tobacco smoking, 52.1 per cent, self-reported overweight, and 16.9 per cent, obesity; among protective factors, 5.0 per cent reported fruit and vegetable intake as recommended, and 3.6 per cent, leisure time physical activity; prevalence of seat belt use in front seat was 74.0 per cent; helmet use was reported by 83.5 per cent of motorcyclists; among individuals who performed blood tests, 49.2 per cent had hypercholesterolemia, 46.0 per cent presented some stage of chronic kidney disease, 19.0 per cent, cardiovascular dysfunction according to electrocardiogram, and 5.8 per cent, diabetes. Conclusion: the methodology allowed to know the risk and protective factors for NCD in a small city of Brazil; actions on health promotion, surveillance, prevention and health care are being developed, based on the results of this study.


Subject(s)
Humans , Male , Female , Behavioral Risk Factor Surveillance System , Information Systems , Risk Factors , Adult , Chronic Disease
12.
Rev. Pan-Amazônica Saúde (Online) ; 1(2): 113-120, 2010. ilus, tab
Article in Portuguese | Coleciona SUS | ID: biblio-945905

ABSTRACT

O artigo apresenta o estudo sobre a adesão ao tratamento em pacientes hipertensos atendidos na Unidade Municipal de Saúde de Fátima no Município de Belém, Estado do Pará, Brasil. Foram entrevistados 100 pacientes no período de setembro a outubro de 2008 para a medida de adesão ao tratamento utilizando a escala de Likert modificada para mensurar o grau de adesão ao tratamento farmacológico, estudando as variáveis que possam estar relacionadas ao grau de adesão, tais como: aos fatores socioeconômicos; à equipe e ao serviço de saúde; à condição da doença; ao tratamento e aquelas relacionadas ao paciente. Também foram investigados dados secundários em prontuários clínicos. Os dados obtidos com as ferramentas de estudo foram plotados no programa Microsoft Office Excel 2003® para análise. Do total de pacientes estudados, 45 por cento foram estabelecidos como de "maior adesão" e 55 por cento como de "menor adesão". Observou-se predomínio de: sexo feminino (68 por cento), faixa etária entre 61 e 75 anos de idade (60 por cento), baixo grau de escolaridade (76 por cento), casados (51 por cento), de cor parda (54 por cento), aposentados (72 por cento) e com renda de um salário mínimo (76 por cento). Quanto à não adesão ao tratamento, infere-se como possíveis causas as variáveis "classificação da pressão arterial com tratamento", "quantidade utilizada de medicamentos para hipertensão arterial sistêmica", "efeito colateral do(s) remédio(s)" e "associação com outras doenças". Estratégias vêm sendo identificadas para minimizar o baixo grau de adesão, porém de forma isolada e unidimensional. Uma abordagem multifocal e multiprofissional é fundamental para o sucesso terapêutico desses pacientes...


This article presents a study about treatment adherence in patients with hypertension treated at the Municipal Health Unit of Fátima in Belém, Pará, Brazil. Between September 2008 and October 2008, we interviewed one hundred patients utilizing a modified version of the measurement of treatment adherence, an assessment that uses a Likert scale to measure levels of adherence to pharmacological treatment. We also obtained data concerning variables that are potentially related to levels of adherence, such as socioeconomic factors, health teams and service, disease severity, treatment and patient-related factors and investigated secondary data from the medical records. Data obtained were plotted in the Microsoft Office Excel 2003® program for analysis. Of the sample, 45 per cet were classified as having "high adherence", and 55 per cent were classified as having "low adherence". The majority of the sample were of female gender (68 per cent), were between the age of 61 and 75 (60 per cent), had low levels of education (76 per cent), were married (51 per cent), were of pardo race (54 per cent), were retired (72 per cent) and earned minimum wage (76 per cent). Regarding possible causes for lack of treatment compliance, we identified the following variables: "classification of blood pressure according to treatment", "number of medications used to treat hypertension", "medication side effects" and "association with other diseases". Several strategies have been identified to minimize low levels of adherence; however, these often occur in an isolated and unidimensional manner. A multi-focal, multi-professional approach is fundamental for the therapeutic success of these patients...


Subject(s)
Male , Female , Humans , Clinical Trials as Topic , Cross-Sectional Studies , Drug Evaluation , Hypertension/diagnosis , Medication Adherence , Preventive Health Services/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL
...